Huntington National Bank
AMPH icon

Huntington National Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Huntington National Bank’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Buy
+525
New +$10.6K ﹤0.01% 2001
2026
Q1 		– Sell
-191
Closed -$5.12K – 4213
2025
Q4 		$5.12K Sell
191
-80
-30% -$2.06K ﹤0.01% 1989
2025
Q3 		$7.22K Buy
271
+18
+7% +$465 ﹤0.01% 1916
2025
Q2 		$5.81K Sell
253
-371
-59% -$9.21K ﹤0.01% 1954
2025
Q1 		$18.1K Sell
624
-716
-53% -$22.9K ﹤0.01% 1557
2024
Q4 		$49.8K Buy
1,340
+361
+37% +$16.5K ﹤0.01% 1201
2024
Q3 		$47.5K Buy
979
+90
+10% +$3.95K ﹤0.01% 1198
2024
Q2 		$35.6K Buy
889
+56
+7% +$2.32K ﹤0.01% 1261
2024
Q1 		$36.6K Buy
833
+72
+9% +$3.72K ﹤0.01% 1240
2023
Q4 		$47.1K Buy
761
+516
+211% +$27.1K ﹤0.01% 1100
2023
Q3 		$11.3K Buy
245
+28
+13% +$1.53K ﹤0.01% 1525
2023
Q2 		$12.5K Sell
217
-212
-49% -$9.4K ﹤0.01% 1500
2023
Q1 		$16.1K Sell
429
-23
-5% -$754 ﹤0.01% 1404
2022
Q4 		$12.7K Buy
452
+41
+10% +$1.19K ﹤0.01% 1425
2022
Q3 		$12K Buy
411
+325
+378% +$10.6K ﹤0.01% 1468
2022
Q2 		$3K Buy
+86
New +$3.07K ﹤0.01% 1806

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Huntington National Bank's AMPH Position: Q2 2026 in Review

Huntington National Bank opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 525 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #2001 among its holdings. This is a return to the name: Huntington National Bank previously reported a position in AMPH as recently as Q4 2025.

Huntington National Bank first reported a position in AMPH in Q2 2022 and has held it in 16 quarters since. The position peaked at $49.8K in Q4 2024. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Huntington National Bank held 525 shares of Amphastar Pharmaceuticals worth $10.6K as of Q2 2026.
  • Amphastar Pharmaceuticals was a new Huntington National Bank position in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2001 holding.
  • Huntington National Bank first reported a position in Amphastar Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • Huntington National Bank's Amphastar Pharmaceuticals position peaked at $49.8K in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.